Overview of GLP-1 Medications (Ozempic, Wegovy, and Others.)
GLP-1 (glucagon-like peptide-1) medications, including Ozempic, are primarily prescribed for diabetes management, helping to regulate blood sugar by stimulating insulin release. Recently, these drugs have also gained popularity for weight loss, especially among individuals seeking alternatives to traditional obesity treatments. While GLP-1 medications have proven effective in many cases, they come with significant risks.
Concerns have emerged around the safety of these drugs, as patients report severe side effects. Gastrointestinal complications, pancreatitis, and thyroid issues have been among the reported reactions, raising red flags for patients and healthcare providers alike. Evidence continues to surface regarding the potential long-term risks of GLP-1 drugs, prompting many to question the adequacy of safety warnings provided by manufacturers.